Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. controlThere are no OCU410-related serious ...

Eric brings extensive experience in dairy nutrition, animal health and territory development, having worked closely with ...

New research has found that the benefits of graded sensorimotor retraining are likely to be similar for all patients with ...

Developer Embark Studios releases a new ARC Raiders update for January 2026, as patch 1.11.0 brings some big balance ...

ExxonMobil Chemical, in collaboration with Milliken & Company and materials recycler Ravago, has published a new case study ...

A significant milestone in Ocugen's development of a gene therapy for Stargardt disease has triggered a substantial rally in the company's stock. The catalyst was the publication of positive Phase 1 ...

Dungeons & Dragons' bloody handed new subclass is part Bhaalspawn, part Dark Urge, all teleporting terror - here's how to ...

Study supports favorable safety and tolerability profile and clinically meaningful functional and structural benefits in ...

Printing injects control into your life that feels almost illicit, and nowhere is this more apparent than in the mechanical ...

Welcome to Tool Tip Tuesday for Adobe Premiere Pro on ProVideo Coalition Whether or not you’re a frequent reader, what got ...

Treating acute myeloid leukemia (AML) depends on knowing what goes wrong inside cells. A new study suggests that two genetic ...